000 | 01343 a2200313 4500 | ||
---|---|---|---|
005 | 20250517204909.0 | ||
264 | 0 | _c20181105 | |
008 | 201811s 0 0 eng d | ||
022 | _a1469-0691 | ||
024 | 7 |
_a10.1016/j.cmi.2018.02.031 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMikulska, M | |
245 | 0 | 0 |
_aFluoroquinolone prophylaxis during neutropenia: what can we expect nowadays? _h[electronic resource] |
260 |
_bClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases _cJul 2018 |
||
300 |
_a678-679 p. _bdigital |
||
500 | _aPublication Type: Letter | ||
650 | 0 | 4 | _aAntibiotic Prophylaxis |
650 | 0 | 4 | _aDisease Management |
650 | 0 | 4 | _aDrug Resistance, Microbial |
650 | 0 | 4 |
_aFluoroquinolones _xtherapeutic use |
650 | 0 | 4 |
_aHematologic Neoplasms _xcomplications |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aNeutropenia _xcomplications |
650 | 0 | 4 |
_aOpportunistic Infections _xetiology |
650 | 0 | 4 | _aOutcome Assessment, Health Care |
700 | 1 | _aCordonnier, C | |
773 | 0 |
_tClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases _gvol. 24 _gno. 7 _gp. 678-679 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.cmi.2018.02.031 _zAvailable from publisher's website |
999 |
_c28188630 _d28188630 |